Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Pascal Rathelot is active.

Publication


Featured researches published by Pascal Rathelot.


European Journal of Medicinal Chemistry | 2002

1,3-Diphenylpyrazoles: synthesis and antiparasitic activities of azomethine derivatives

Pascal Rathelot; Nadine Azas; Hussein El-Kashef; Florence Delmas; Carole Di Giorgio; P. Timon-David; José Maldonado; Patrice Vanelle

1,3-Diphenylpyrazole-4-carboxaldehyde and 1-(4-nitrophenyl)-3-phenylpyrazole-4-carboxaldehyde were obtained from the appropriated phenylhydrazones via the Vilsmeier-Haack reaction. These two aldehydes were functionalized by various substituted anilines or substituted benzylamines. Antiparasitic activities of the corresponding azomethines were assessed. In the most cases, nitrated compounds were found to be more efficient than non-nitrated ones against Plasmodium falciparum, Trichomonas vaginalis and Leishmania infantum.


Bioorganic & Medicinal Chemistry | 2009

Synthesis and in vitro antiplasmodial evaluation of 4-anilino-2-trichloromethylquinazolines

Pierre Verhaeghe; Nadine Azas; Sébastien Hutter; Caroline Castera-Ducros; Michèle Laget; Aurélien Dumètre; M. Gasquet; Jean-Pierre Reboul; Sylvain Rault; Pascal Rathelot; Patrice Vanelle

To identify a new safe antiplasmodial molecular scaffold, an original series of 2-trichloromethylquinazolines, functionalized in position 4 by an alkyl- or arylamino substituent, was synthesized from 4-chloro-2-trichloromethylquinazoline 1, via a cheap, fast and efficient solvent-free operating procedure. Among the 40 molecules prepared, several exhibit a good profile with both a significant antiplasmodial activity on the W2 Plasmodium falciparum strain (IC(50) values: 0.4-2.2 microM) and a promising toxicological behavior regarding human cells (HepG2/W2 selectivity indexes: 40-83), compared to the antimalarial drug compounds chloroquine and doxycycline. The in vitro antitoxoplasmic and antileishmanial evaluations were conducted in parallel on the most active molecules, showing that these ones specifically display antiplasmodial properties.


European Journal of Medicinal Chemistry | 1995

Synthesis of novel functionalized 5-nitroisoquinolines and evaluation of in vitro antimalarial activity

Pascal Rathelot; Patrice Vanelle; M. Gasquet; Florence Delmas; Michel P. Crozet; P. Timon-David; José Maldonado

Summary Novel aldimine and hydrazone isoquinoline derivatives were obtained after subjecting 1-formyl-5-nitroisoquinoline to classical reactions. Some of these compounds were found to have activity against a chloroquine-resistant Plasmodium falciparum strain (ACC Niger).


European Journal of Medicinal Chemistry | 2012

Discovery of a new antileishmanial hit in 8-nitroquinoline series.

Lucie Paloque; Pierre Verhaeghe; Magali Casanova; Caroline Castera-Ducros; Aurélien Dumètre; Litaty Mbatchi; Sébastien Hutter; Manel Kraiem-M'Rabet; Michèle Laget; Vincent Remusat; Sylvain Rault; Pascal Rathelot; Nadine Azas; Patrice Vanelle

A series of nitrated 2-substituted-quinolines was synthesized and evaluated in vitro toward Leishmania donovani promastigotes. In parallel, the in vitro cytotoxicity of these molecules was assessed on the murine J774 and human HepG2 cell lines. Thus, a very promising antileishmanial hit molecule was identified (compound 21), displaying an IC(50) value of 6.6 μM and CC(50) values ≥ 100 μM, conferring quite good selectivity index to this molecule, in comparison with 3 drug-compounds of reference (amphotericin B, miltefosine and pentamidine). Compound 21 also appears as an efficient in vitro antileishmanial molecule against both Leishmania infantum promastigotes and the intracellular L. donovani amastigotes (respective IC(50) = 7.6 and 6.5 μM). Moreover, hit quinoline 21 does not show neither significant antiplasmodial nor antitoxoplasmic in vitro activity and though, presents a selective antileishmanial activity. Finally, a structure-activity relationships study enabled to define precisely the antileishmanial pharmacophore based on this nitroquinoline scaffold: 2-hydroxy-8-nitroquinoline.


Green Chemistry | 2009

An efficient aqueous microwave-assisted Suzuki–Miyaura cross-coupling reaction in the thiazole series

Anita Cohen; Maxime D. Crozet; Pascal Rathelot; Patrice Vanelle

A new simple, rapid and high yielding synthesis of various 5-substituted thiazoles by Suzuki–Miyaura cross-coupling reaction is described using microwave irradiation in aqueous medium without organic co-solvent in the presence of tetrabutylammonium bromide.


Journal of Chromatography B | 2011

Determination of uremic solutes in biological fluids of chronic kidney disease patients by HPLC assay.

Raymond Calaf; Claire Cerini; Cécile Génovésio; Pierre Verhaeghe; Noémie Jourde-Chiche; David Bergé-Lefranc; Bertrand Gondouin; Laetitia Dou; Sophie Morange; Àngel Argilés; Pascal Rathelot; Françoise Dignat-George; Philippe Brunet; Philippe Charpiot

During chronic kidney disease (CKD), solutes called uremic solutes, accumulate in blood and tissues of patients. We developed an HPLC method for the simultaneous determination of several uremic solutes of clinical interest in biological fluids: phenol (Pol), indole-3-acetic acid (3-IAA), p-cresol (p-C), indoxyl sulfate (3-INDS) and p-cresol sulfate (p-CS). These solutes were separated by ion-pairing HPLC using an isocratic flow and quantified with a fluorescence detection. The mean serum concentrations of 3-IAA, 3-INDS and p-CS were 2.12, 1.03 and 13.03 μM respectively in healthy subjects, 3.21, 17.45 and 73.47 μM in non hemodialyzed stage 3-5 CKD patients and 5.9, 81.04 and 120.54 μM in hemodialyzed patients (stage 5D). We found no Pol and no p-C in any population. The limits of quantification for 3-IAA, 3-INDS, and p-CS were 0.83, 0.72, and 3.2 μM respectively. The within-day CVs were between 1.23 and 3.12% for 3-IAA, 0.98 and 2% for 3-INDS, and 1.25 and 3.01% for p-CS. The between-day CVs were between 1.78 and 5.48% for 3-IAA, 1.45 and 4.54% for 3-INDS, and 1.19 and 6.36% for p-CS. This HPLC method permits the simultaneous and quick quantification of several uremic solutes for daily analysis of large numbers of samples.


Bioorganic & Medicinal Chemistry Letters | 2011

4-Thiophenoxy-2-trichloromethyquinazolines display in vitro selective antiplasmodial activity against the human malaria parasite Plasmodium falciparum

Pierre Verhaeghe; Aurélien Dumètre; Caroline Castera-Ducros; Sébastien Hutter; Michèle Laget; Cyril Fersing; Marion Prieri; Julien Yzombard; Sylvain Rault; Pascal Rathelot; Patrice Vanelle; Nadine Azas

A series of original quinazolines bearing a 4-thiophenoxy and a 2-trichloromethyl group was synthesized in a convenient and efficient way and was evaluated toward its in vitro antiplasmodial potential. The series revealed global good activity against the K1-multi-resistant Plasmodium falciparum strain, especially with hit compound 5 (IC(50)=0.9 μM), in comparison with chloroquine and doxycycline chosen as reference-drugs. Both the in vitro cytotoxicity study which was conducted on the human HepG2 cell line and the in vitro antitoxoplasmic screening against Toxoplasma gondii indicate that this series presents an interesting selective antiplasmodial profile. Structure-activity- and toxicity relationships highlight that the trichloromethyl group plays a key role in the antiplasmodial activity and also show that the modulation of the thiophenol moiety influences the toxicity/activity ratio.


Journal of Pharmacy and Pharmaceutical Sciences | 2012

Organic Glues or Fibrin Glues from Pooled Plasma: Efficacy, Safety and Potential as Scaffold Delivery Systems

Clémence Tabélé; Marc Montana; Christophe Curti; Thierry Terme; Pascal Rathelot; Sophie Gensollen; Patrice Vanelle

Since 1976, fibrin glues have been attracting medical interest, spreading from their initial use as a hemostatic agent in cardiovascular surgery to other fields of surgery. Studies have compared the efficacy of fibrin glues vs sutures in surgery. However, few comparisons have been made of the efficacy and safety of the different fibrin glues commercially available. Recently, fibrin glues have been tested as a scaffold delivery system for various substances inside the body (drugs, growth factors, stem cells). The infectious risk (viruses, new germs) of this blood-derived product was also studied in assays on viral inactivation methods. The development of autologous fibrin glues offers a solution to the problem of infectious risk. This review examines the current state of knowledge on the efficacy, safety and future potential of fibrin glues.


European Journal of Medicinal Chemistry | 2011

Targeting the human malaria parasite Plasmodium falciparum: in vitro identification of a new antiplasmodial hit in 4-phenoxy-2-trichloromethylquinazoline series.

Caroline Castera-Ducros; Nadine Azas; Pierre Verhaeghe; Sébastien Hutter; Philippe Garrigue; Aurélien Dumètre; Litaty Mbatchi; Michèle Laget; Vincent Remusat; Sylvain Rault; Pascal Rathelot; Patrice Vanelle

From the promising results we previously obtained in quinazoline series and to complete the evaluation of the in vitro antiplasmodial activity of original 2-trichloromethylquinazolines, we synthesized new quinazolines possessing a variously substituted phenoxy group at position 4 through a simple and efficient two-step-synthesis approach. The studies of their activity toward the multi-resistant W2 Plasmodium falciparum strain and of their cytotoxicity on the human hepatocyte HepG2 cell line highlighted a hit compound (molecule 7) displaying a W2 IC(50) value of 1.1 μM and a HepG2 CC(50) value of 50 μM, comparable to chloroquine and doxycycline. Structure-activity- and toxicity relationships indicate that the trichloromethyl group plays a key role in the antiplasmodial activity of such chemical scaffold and also that the phenoxy group substitution as a direct influence on the molecules selectivity. Moreover, molecule 7 displays significant specific activity against the Plasmodium genus in comparison with Toxoplasma and does not show any mutagenic property at the Ames test.


Heterocycles | 2002

Microwave Assisted Synthesis of New Benzimidazoles

Patrice Vanelle; Yves Njoya; Narimène Boufatah; Armand Gellis; Pascal Rathelot; Michel P. Crozet

New potentially bioactive and highly functionalized benzimidazoles were synthesized by using microwave irradiation methodology in multi-steps: construction of benzimidazole ring, N-methylation and electron transfer C-alkylation (followed by base-promoted nitrous acid elimination) or S-alkylation.

Collaboration


Dive into the Pascal Rathelot's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Nadine Azas

Aix-Marseille University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Pierre Verhaeghe

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

Michèle Laget

Aix-Marseille University

View shared research outputs
Top Co-Authors

Avatar

Pierre Verhaeghe

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

Anita Cohen

Aix-Marseille University

View shared research outputs
Top Co-Authors

Avatar

Michel P. Crozet

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge